Most Hepatitis C infections cured by experimental drug

A new drug for Hepatitis C was found to essentially cure patients good news for the nearly four million Americans with the disease.

The experimental drug telaprevir was found to eliminate Hepatitis C in seventy-five percent of patients given the drug for six months compared to forty percent of those given standard therapy. Over one thousand patients participated in the study.

The drug has not been approved by the FDA, but experts are hopeful that if it is, it will permanently change the landscape of hepatitis C treatment.